Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Serina Therapeutics, Inc. (SER) had Return on Investments of -288.27% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.58M |
|
-- |
|
-- |
|
$6.39M |
|
$-6.39M |
|
$1.80M |
|
$-4.59M |
|
$-4.59M |
|
$-4.59M |
|
$-4.59M |
|
$-4.59M |
|
$-4.59M |
|
$-6.39M |
|
$-6.38M |
|
10.34M |
|
10.34M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$11.50M |
|
$0.58M |
|
$0.92M |
|
$12.41M |
|
$8.79M |
|
-- |
|
$2.03M |
|
$10.82M |
|
$-3.35M |
|
$1.59M |
|
$1.59M |
|
10.54M |
|
| Cash Flow Statement Financials | |
$-11.92M |
|
$-0.06M |
|
$16.93M |
|
$3.67M |
|
$8.62M |
|
$4.95M |
|
$2.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
1.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
137.33% |
|
-288.27% |
|
-37.02% |
|
|
Return on Investments |
-288.27% |
$0.15 |
|
$-1.16 |
|
$-1.15 |
|